Protamine peptide (PP) derived from salmon is a 14-mer with 10 arginine residues. We investigated the in vitro and in vivo antifungal activity of PP against Candida albicans. PP showed a concentration-dependent dual mode of action, with fungicidal activity and inhibitory activity for hyphal development in vitro. At lethal concentrations of PP, intracellular accumulation of PP was energy-dependent but independent of endocytosis, and resulted in ATP efflux and the generation of reactive oxygen species in the cells. PP at sublethal concentrations inhibited hyphal development in C. albicans by binding to the cell surface. Though antifungal activity of PP was inactivated by high concentrations of NaCl, the antifungal activity of the synthetic cyclic (via a disulfide bond) form of PP (cyclic PP) was not. Cyclic PP also showed the concentration-dependent dual mode of action, and had five-fold greater antifungal activity than PP. The advantage of antifungal activity of cyclic PP compared with PP in vitro resulted in a high in vivo efficacy in a murine oral candidiasis model. Oral treatment with cyclic PP inhibited hyphal development of C. albicans on mouse tongues and protected against the development of severe candidiasis. This study shows the therapeutic potential of cyclic PP as an antifungal peptide against C. albicans.
INTRODUCTION
Candida albicans is a commensal of human mucosal tissues (oral, vaginal and gastrointestinal) and skin. It can become pathogenic, often in an opportunistic infection such as oral candidiasis in individuals with immune defects. An increase in the number of reports on the emergence of strains resistant against frontline antifungal agents reveals a potential health issue (Pfaller et al. 2002) . Antifungal peptides are considered to be promising alternative antifungal candidates. To date, many antifungal peptides have been discovered, and they generally have a cationic and/or amphipathic nature (Matejuk et al. 2010) . Several peptides, such as MUC7 of salivary mucin (Bobek and Situ 2003) , ApoEdpL-W of the receptor-binding region of human apolipoprotein E (Rossignol et al. 2011 ) and salivary histatin-5 (Hst-5) (Edgerton et al. 2000) , exhibit their antifungal activity through intracellular targeting. However, their peptide structures and modes of action are highly diverse, including their salt sensitivity, mechanism of cellular internalization and intracellular targeting.
Protamine is an arginine-rich protein found in salmon spermatozoa nuclei that has antimicrobial activity against a broad spectrum of bacteria (Uyttendaele and Debevere 1994; Aspedon and Groisman 1996; Johansen et al. 1997) , but it shows no activity against fungi (Kamel, Motohiro and Itakura 1986) . Denture stomatitis is a common intraoral inflammatory condition that is associated with a C. albicans biofilm adhering to dental prostheses (Salerno et al. 2011) . Miura et al. (2010) reported that a protamine hydrolysate, following treatment by the proteolytic enzyme thermolysin, inhibited attachment of C. albicans to polymethyl methacrylate more efficiently compared to protamine. Iohara et al. (2009) found that the peptide sequence VSRRRRRRGGRRRR (protamine peptide; PP) from the protamine hydrolysates showed antifungal activity against C. albicans. However, the mechanisms that resulted in the peptide's antifungal activity remain unknown. In this study, we investigated the mechanisms by which PP acts against C. albicans in vitro. We further synthesized a cyclized form of PP, via a disulfide bond, to enhance the antifungal activities of PP and evaluated its efficacy in vitro and in a murine oral candidiasis model.
MATERIALS AND METHODS

Fungal strains
Candida albicans strain SC5314 (Gillum, Tsay and Kirsch 1984) was used in this study and was maintained as a frozen glycerol stock at −80
• C. To obtain fresh cells, YPD agar plates (1% yeast extract, 2% Bacto-peptone, 2% glucose and 1.5% agar) were streaked and incubated at 37
• C for 24 h. Candida albicans strain TIMM 1768 was used only for a murine oral candidiasis model. We also tested non-albicans species of Candida such as C. glabrata IFM46861, C. tropicalis IFM46862 and C. krusei IFN5462.
Peptide preparation
PP (VSRRRRRRGGRRRR), its N-terminal fluorescein isothiocyanate (FITC)-labeled PP (FITC-PP), cyclic PP (CRRRRRRGGR-RRRC; cyclized via a disulfide bond), and Hst-5 (DSHAKRHH-GYKRKFHEKHHSHRGY) were chemically synthesized by Medical & Biological Laboratories Co., Ltd (Nagoya, Japan). The peptides were more than 98% pure, and their molecular mass was validated by mass spectrometry. The peptides were dissolved in distilled water and stored at −20 • C.
Minimum inhibitory concentration measurement
Candida albicans was cultured in 1:10 diluted Sabouraud dextrose broth (SDB; Difco, BD, Franklin Lakes, NJ, USA) containing various concentrations of PP and Hst-5 with an inoculum of 1 × 10 3 cells mL −1 in a 96-well plate (Becton Dickinson). Growth inhibition was determined by measuring the optical density at 600 nm using Sunrise Rainbow RC-R (Tecan, Männedrof, Switzerland) after incubation at 37
• C for 24 h. A minimum inhibitory concentration (MIC) was determined by measuring the concentration required to inhibit the growth of 90% of C. albicans yeast cells.
Minimum fungicidal concentration measurement
Candida albicans was incubated with various concentrations of PP and Hst-5 in 10 mM phosphate buffer at 37
• C for 2 h, and the mixture was plated on YPD agar plates and incubated at 37
• C for 24 h to determine colony forming units (CFUs). A minimum fungicidal concentration (MFC) was defined as the concentration required for 10% decrease of the CFUs compared with the initial inoculum of C. albicans yeast cells.
Antifungal spectrum
To determine the antifungal spectrum of PP and His-5 against Candida spp., Candida spp. were incubated in 10 mM phosphate buffer (PB, pH 7.2) with various concentrations of each peptide at 37
• C for 2 h and the residual metabolic activity was determined by measuring with the Microbial Viability Assay Kit-WST (Dojindo, Kumamoto, Japan). Briefly, the Microbial Viability Assay Kit-WST can be used to determine the number of viable bacterial and fungal cells by a colorimetric method. The electron mediator in the kit receives electrons from NAD(P)H of viable microbial cells and transfers the electrons to WST, one of the watersoluble tetrazolium salts in the kit. Microbial cell viability then can be determined by monitoring the color intensity of WST formazan dye by measuring the absorbance at 450 nm (Tsukatani et al. 2009 (Tsukatani et al. , 2014 .
Salt sensitivity test
To test salt sensitivity, C. albicans cells were treated with the peptides (10 μM) in 10 mM phosphate buffer containing various concentrations of NaCl and incubated at 37
• C for 2 h, and the resid- 
Effect of the inhibitors on PP antifungal activity
The effects of sodium azide and latrunculin B on the antifungal activity of PP were evaluated by counting CFUs as described by Rossignol et al. (2011) . Briefly, the C. albicans yeast cells were treated with 10 mM sodium azide (Kanto Chemical, Tokyo, Japan) or the endocytosis inhibitor latrunculin B (10 mg mL −1 ;
Wako, Osaka, Japan) in 10 mM phosphate buffer at 37
• C for 1 h before incubation with PP (10 μM).
Effect on hyphal development of C. albicans
To elucidate the effect of PP and cyclic PP on C. albicans morphology, yeast cells (1 × 10 6 cells mL −1 ) harvested from YPD agar plates were incubated in Spider medium (Liu, Kohler and Fink 1994) containing various concentrations of PP or cyclic PP at 37
• C, and the morphology was observed microscopically (Biorevo BZ-9000; Keyence, Osaka, Japan). Unless otherwise noted, experiments were performed in flat glass-bottomed 96-well plates (Iwaki, Tokyo, Japan).
Cell localization of PP
The C. albicans cells (1 × 10 6 cells mL −1 ) were treated with FITC-PP in Spider medium or 10 mM phosphate buffer at 37
• C for 2 h and fixed with formalin. Localization of FITC-PP in the C. albicans cells was observed with fluorescence microscopy (Biorevo BZ-9000). 
Detection of internalized PP
Cellular ATP efflux
ATP released from C. albicans after 1 h peptide exposure in Spider medium was measured as described by Koshlukova et al. (1999) . The cells (1 × 10 6 cells mL −1 ) treated with the peptides were pelleted, and 50 μL of the supernatant was added to 450 μL of boiling TE buffer (50 mM Tris, 2 mM EDTA, pH 7.8), boiled for an additional 90 s, and stored on ice until assayed for ATP. ATP levels were measured by luminometry using an ATP Assay Kit (Sigma, St Louis, MO, USA) according to the manufacturer's instructions. Briefly, 50 μL of the boiled supernatant-TE mixture containing the extracellular content was deposited in the well of a flat-bottomed polystyrene 96-well plate (BD, Franklin Lakes, NJ, USA), and 100 μL of the luciferin-luciferase assay mixture was added. Light emission was monitored using a luminometer (Wallac 1420 ARVO MX; Perkin Elmer, Waltham, MA, USA), and the results are expressed in bioluminescence relative light units. The ATP concentrations were determined from ATP standard curves.
Measurement of reactive oxygen species
Reactive oxygen species (ROS) generated in C. albicans were detected with 3 -(p-hydroxyphenyl) fluorescein (HPF; Molecular Probes, OR, USA) according to the manufacturer's protocol. HPF is preferentially oxidized by intracellular hydroxyl radicals into a fluorescent product. Candida albicans cells (1 × 10 6 cells mL −1 )
were treated with the peptides at 37
• C for 1 h in Spider medium followed by incubation with 10 μM HPF at 37
• C for 30 min. The cells were washed twice with 10 mM phosphate buffer, and ROS generation was detected by fluorescence microscopy (BIOREVO BZ-9000).
Murine oral candidiasis model
All animal experiments were performed in accordance with the guidelines for the care and use of animals approved by Teikyo University. The murine oral candidiasis model has been described previously (Takakura et al. 2003; Ishijima et al. 2012) . Sixweek-old female ICR mice (Charles River Japan, Inc., Yokohama, Kanagawa, Japan) were used for all animal experiments. To induce an immunosuppressed condition, 100 mg of prednisolone (Mitaka Pharmaceutical Co., Japan) per kilogram of body weight was injected subcutaneously into mice 20-24 h before oral inoculation. Prior to prednisolone administration, 4.13 mg mL −1 of tetracycline hydrochloride (SC Environmental Science Co., Ltd, Japan) was administered in drinking water for 24 h. On the day of infection, animals were anesthetized by intramuscular injection into the femur with 14.4 mg kg −1 of chlorpromazine chloride, after which mice were orally inoculated with 2.0 × 10 8 cells mL −1 of C. albicans TIMM1768 in modified RPMI 1640 medium. The number of Candida cells inoculated in the oral cavity was calculated to be 1 × 10 6 cells per mouse on the basis of the difference in viable cell number adhering to the cotton swabs before and just after oral inoculation. The mice infected with C. albicans were treated with 15 μL of 25 mg mL −1 concentration of PP or cyclic PP dissolved in 1% methylcellulose three times at 3, 24 and 27 h post-infection.
Scoring of the severity of oral infection
The severity of oral infection was scored as described previously (Takakura et al. 2003) . Forty-eight hours after inoculation, mice were sacrificed by cervical dislocation, and the severity of tongue lesions was evaluated by scoring the fur coating on each tongue and the squamous disorder as follows: 0, normal; 1, fur on less than 20% of the tongue; 2, fur on more than 21% but less than 90% of the tongue; 3, fur on more than 91% of the tongue and on the squamous layer; 4, thick fur on more than 91% of the tongue and on the squamous layer.
Measurement of viable Candida cells on murine tongues
At 48 h after inoculation, the tongues of each mouse were cut. The tongues were minced in 2 mL of sterile saline and homogenized for 30 s, then diluted 10-or 50-fold in sterile saline. Fifty microliters of each dilution was incubated on a Candida GS agar plate (selection medium for Candida; Eiken Chemical Co. Ltd, Japan) for 20 h at 37
• C. Colonies were counted; data are expressed as the number of CFU per 0.1 g tongue for each treatment.
Histology
For histological study, the tongues were resected at the base, fixed with 4% paraformaldehyde (pH 7.4) at 4
• C, dehydrated with an ethanol series, and embedded in paraffin. Specimens were sectioned to an 8-μm thickness along the longitudinal center line. Sections were stained with periodic acid-Schiff (PAS).
Statistical analysis
The score data were compared by the non-parametric MannWhitney U-test. Statistical analysis of the log 10 number of CFU of C. albicans isolated from each mouse was compared using Student's t-test.
RESULTS
Antifungal activity of PP against Candida spp.
We tried to determine an MIC of PP by measuring growth inhibition of C. albicans yeast cells. However, growth inhibitory activity of PP was not observed in typical laboratory media such as YPD, TSB, or YNB-glucose media, as with the reports for Hst5 owing to its high salt sensitivity (Sun et al. 2008; Jang et al. 2010) . We therefore determined the MIC of PP and Hst-5 by measuring the concentration required to inhibit the growth of 90% of the yeast cells in 1:10 diluted Sabouraud dextrose broth according to a previous report (Rossignol et al. 2011) . The MIC of PP and Hst-5 was 1.6 and 0.8 μM, respectively, indicating that PP showed a slightly higher MIC than Hst-5 (Table 1) . Additionally, we determined an MFC of PP in 10 mM phosphate buffer by measuring the concentration required for 10% decrease of the CFUs compared with initial inoculum of C. albicans yeast cells at 37
• C for 2 h. The MFC of PP and cyclic PP was 2.5 μM and 5.0 μM, respectively. PP had a slightly lower MFC than Hst-5 (Table 1) .
We also investigated the antifungal activity of PP against Candida spp., including C. albicans, C. glabrata, C. tropicalis and C. krusei, by measuring the residual metabolic activity after peptide exposure under non-growth conditions in 10 mM phosphate buffer (Table 2) . Although Hst-5 showed no antifungal activity against C. glabrata at the concentration tested as reported previously (Kumar et al. 2011) , PP at 2.5 μM completely inhibited metabolic activity of all tested Candida spp. 
Effect on hyphal development of C. albicans
To elucidate the effect on hyphal development of C. albicans cells, Spider medium was used, which can induce hyphal development at 37
• C for 2 h. PP at concentrations of less than 50 μM inhibited hyphal growth, whereas a high percentage of untreated cells had elongated long filaments (Fig. 1A) . We further monitored hyphal development for 18 h after PP exposure (Fig. 1B) . PP at 50 μM inhibited cell growth and hyphal development, suggesting a lethal concentration. The untreated cells grew in a hyphal form and formed a thick layer with hyphae after 18 h. However, the cells treated with 10 μM, a sublethal concentration, appeared as both yeast and hyphal forms with short germ tubes in a 2 h incubation and grew mainly as the yeast form in 18 h. These results indicate that sublethal concentrations of PP can inhibit hyphal elongation without affecting yeast cell growth.
ATP efflux and ROS generation by PP
To investigate the mechanisms responsible for the antifungal activity of PP, we measured cellular ATP efflux and ROS generation in C. albicans by PP exposure in Spider medium. A significant amount of ATP efflux was observed at the lethal concentration of PP (50 μM), while no ATP was released at the sublethal concentration (10 μM) (Fig. 1C) . To rule out the possibility that the ATP efflux changes may not be caused by PP directly, but by yeast-hyphal conversion in Spider medium, we determined the ATP efflux of C. albicans cells by PP in 10 mM phosphate buffer.
The data clearly showed a concentration-dependent ATP efflux by PP (Fig. 1D) . Similarly, when we measured ROS generation in the cells after PP exposure, ROS was detected at the lethal concentration (50 μM), but not at the sublethal concentration (10 μM) (Fig. 1E) . These results demonstrated that PP exhibited its antifungal activity by ATP efflux of the cells and ROS generation in the cells.
Cellular localization of PP
PP was labeled with FITC (FITC-PP) to investigate the cellular localization of PP in C. albicans. FITC-PP showed a higher antifungal activity that PP in Spider medium. The lethal concentration of FITC-PP (10 μM) induced similar level of ATP efflux with PP at 50 μM (Fig. 1D) . We showed microscopically that FITC-PP at 10 μM was observed inside of the cells, whereas FITC-PP at the sublethal concentration (2.5 μM) that inhibited hyphal elongation was located at the surface of the cells (Fig. 2A) .
To gain more insight into cellular internalization of the PP, it was further evaluated under non-growth conditions in 10 mM phosphate buffer. To confirm the internalization of the peptides (2 μM), we monitored the internalization of FITC-PP in the cells. The FITC-PP at 2 μM decreased the CFU to the same level as did 10 μM of the unlabeled peptide (data not shown). FITC-PP was observed microscopically inside the cells in this condition (Fig. 2B) . We prepared a cell-free extract from the cells treated or not with the FITC-PP and confirmed its presence with Tricine SDS-PAGE. Fluorescent bands corresponding in size to the FITC-PP and somewhat smaller, slightly degraded peptide were observed (Fig. 2B ). PP at 10 μM showed fungicidal activity where the number of cells treated with PP was reduced from 10 6 CFU mL −1 to 10 3 CFU mL −1 after 2 h incubation (Fig. 2C) . We next investigated whether the antifungal activity and the cellular internalization of PP were mediated by endocytosis; we treated the cells with latruncline B, an endocytosis inhibitor. Latruncline B did not affect the antifungal activity and the internalization of PP (Fig. 2C and D) . We confirmed that vacuolar trafficking with FM4-64, an endocytosis-dependent probe, was inhibited in the latruncline B-treated cells (data not shown). These results suggested that endocytosis is not involved in the cellular internalization of PP. To understand the antifungal mechanism of PP, sodium azide, a metabolic inhibitor, was used to block ATP synthesis in mitochondria. The antifungal activity of PP was drastically affected and FITC-PP was localized to the surface of the cells when cells were pretreated with sodium azide (Fig. 2C and  D) . These results indicated that the sodium azide inhibited the cellular internalization of PP, which resulted in loss of antifungal activity.
Comparison of antifungal activity of PP and cyclic PP in vitro
Peptides that possess a cluster of three or more basic amino acids exhibit various degrees of salt sensitivity (Tam, Lu and Yang 2002) . We investigated the effect of salt concentration on the antifungal activity of PP by measuring the residual metabolic activity after peptide exposure at various concentrations of 100-200 mM NaCl (Fig. 3A) . PP was inactivated depending upon the salt concentration. To compensate for inefficacy of PP in high salt concentration, we synthetically made a cyclic form of PP (cyclic PP). Cyclic PP still showed high antifungal activity even in the 200 mM NaCl condition. We observed a significant difference in viability of C. albicans cells between PP and cyclic PP at 150 and 200 mM NaCl, suggesting that cyclic PP was more active than PP under host physiological conditions such as saline (about 154 mM NaCl).
We further tested the antifungal activity of cyclic PP in Spider medium at 37
• C for 2 h (Fig. 3B) . Cyclic PP also showed the concentration-dependent dual mode of action on antifungal ac- tivity. Cyclic PP completely inhibited hyphal growth at 10 μM, and also inhibited 50% of hyphal development at 2.5 μM. Lethal concentrations of cyclic PP and PP were 10 and 50 μM, respectively. Therefore, cyclic PP showed five-fold greater fungicidal activity than PP. We also measured cellular ATP efflux and ROS generation at the lethal or the sublethal concentrations of cyclic PP ( Fig. 3C and D) . Cyclic PP at lethal but not at sublethal concentrations strongly induced cellular ATP efflux and ROS generation ( Fig. 3C and D) . These results demonstrated that cyclic PP showed the same mode of action with PP, and exhibited higher antifungal activity than PP.
Antifungal activity of linear and cyclic protamine peptides on an oral candidiasis model
The effects of PP and cyclic PP on murine oral candidiasis were examined. PP was coated with 1% methylcellulose on whole tongues at 24 and 27 h after C. albicans inoculation. Cyclic PP caused an improvement in symptom score, although PP was not effective (Fig. 4A ). The CFUs of C. albicans from excised tongues were similar with both types of PP (Fig. 4B) . However, the reduced pathogenicity of C. albicans cells when mice were treated with cyclic PP was illustrated by the histopathology of tongue sections (Fig. 4C ). PAS-staining C. albicans cells on the tongues in the cyclic PP group were mostly the yeast form, whereas the cells on the tongues in the PP group and in the control group were the yeast and mycelial forms. These results indicated that cyclic PP showed higher efficacy on murine oral candidiasis than PP.
DISCUSSION
In this study, we demonstrated the antifungal activity of PP derived from salmon protamine and its cyclized form, cyclic PP, against C. albicans in vitro and in vivo. PP exhibited concentrationdependent modes of action: fungicidal activity at lethal concentration via cellular internalization, and inhibition of hyphal development at sublethal concentration by binding to the cell surface. The fungicidal activity of PP was due, in part, to ATP efflux and ROS generation following its internalization by an energy-dependent mechanism, not by endocytosis. Similarly, the fungicidal activity of Hst-5 resulted from ATP efflux and ROS generation after translocation into C. albicans cells in an energydependent manner (Koshlukova et al. 1999; Helmerhorst, Troxler and Oppenheim 2001) . The intracellular behavior of PP that causes ATP efflux and ROS generation needs to be further explored. Kumar et al. (2011) reported that Hst-5 uptake occurs through intracellular translocation into the cytoplasm by the polyamine transporter Dur3p/Dur31p. In addition, Hst-5 accumulated in the vacuoles at non-lethal concentrations, but it was targeted to the cytoplasm at lethal concentrations (Mochon and Liu 2008) . We propose that PP utilizes a different cellular internalization mechanism compared with Hst-5 and this different mechanism may result in antifungal activity of PP against C. glabrata. Given that morphogenesis to the hyphal form is a virulence factor of C. albicans, so far several small molecules have been reported to modulate the yeast-to-hyphal transition in C. albicans (Shareck and Belhumeur, 2011) . PP at the sublethal concentration, located on the cell surface, inhibited hyphal development, and this may play an important role in reducing the pathogenesis of C. albicans. The addition of high concentrations of NaCl (>100 mM) has been shown to inhibit the activity of many cationic antimicrobial peptides (Hancock and Sahl 2006) , which suggests their applica- tion is limited. PP has 10 arginine residues out of 14 amino acid residues (pI = 12.95); therefore, electrostatic interactions may be important for the initial binding to the C. albicans cell surface. In fact, the antifungal activity of PP was inhibited by high salt concentrations. The concentration of PP required for antifungal activity was higher in Spider medium than it was in 10 mM phosphate buffer, perhaps due to the higher salt concentration of the Spider medium. Cyclized peptides show better biological activity compared with their linear counterparts due to features such as conformational rigidity, receptor selectivity, biochemical stability and membrane permeability (Joo 2012) . Our data demonstrated that cyclic PP showed antifungal activity under high salt conditions and had high potentiality as an antifungal peptide compared with PP in vitro. Higher efficacy of cyclic PP than PP in a murine model of oral candidiasis was correlated with in vitro results. Mice treated with cyclic PP showed inhibited mycelial growth of C. albicans on their tongues. The data obtained in this study suggest that cyclic PP may have merit for further clinical investigations to determine its activity in the treatment of oral candidiasis.
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